BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7083785)

  • 1. [Biopsy study of chronic alcoholic hepatopathies. Assessment of the steatosis in the course of arginine thiazolidinecarboxylate treatment].
    Mauro G; Vigiani L
    Clin Ter; 1982 Feb; 100(4):359-74. PubMed ID: 7083785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-pathological study of the therapeutic efficiency of carbamizole in the treatment of human alcoholic hepatitis].
    Sánchez Lombraña JL; Pérez R; Rodrigo L; González M; Saavedra LG; Linares A; Arce D
    Rev Esp Enferm Apar Dig; 1984 Mar; 65(3):233-8. PubMed ID: 6729186
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunohistochemical studies on the occurrence of HBs antigen in alcoholic fatty liver and alcoholic fatty liver hepatitis].
    Thaler H; Beham A
    Wien Klin Wochenschr; 1986 Mar; 98(5):151-5. PubMed ID: 3515768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver biopsy changes in chronic alcoholism].
    Lorenz G
    Z Gesamte Inn Med; 1978 Mar; 33(5):145-8. PubMed ID: 645147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic liver damage of alcoholics].
    András K; Zsuzsa S; Károly L; Béla P; Imre V; János S
    Orv Hetil; 1978 Jun; 119(23):1409-12. PubMed ID: 662319
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristic features of liver disease in Japanese alcoholics.
    Sugimoto M; Hatori T; Ito T; Furube M; Abei T
    Am J Gastroenterol; 1985 Dec; 80(12):993-7. PubMed ID: 4073006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinico-pathological study of the liver damage in alcoholic patients].
    Insunza I; Iturriaga H; Ugarte G; Altschiller H
    Rev Med Chil; 1969 Dec; 97(12):765-72. PubMed ID: 4157359
    [No Abstract]   [Full Text] [Related]  

  • 8. [5-year follow-up studies of alcoholic liver diseases].
    Nagy G; Ujszászy L; Nagy K; Prónay G
    Orv Hetil; 1981 Jul; 122(27):1643-6. PubMed ID: 7290672
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential phospholipids in the treatment of alcohol-induced steatosis and hepatitis].
    Katuscák I; Hendrich F; Vladár L; Valentík M; Horáková M; Lauko L
    Cas Lek Cesk; 1988 Apr; 127(18):556-9. PubMed ID: 3293785
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphology of alcoholic liver disease.
    Lefkowitch JH
    Clin Liver Dis; 2005 Feb; 9(1):37-53. PubMed ID: 15763228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatohepatitis: comparison of alcoholic and non-alcoholic subjects with particular reference to portal hypertension and hepatic complications.
    Crawford DH; Powell EE; Searle J; Powell LW
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():36-8. PubMed ID: 2519082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of alcoholic hepatopathies].
    Salerno MT; Ventrella F; Calò Gabrieli G
    Clin Ter; 1986 May; 117(4):311-6. PubMed ID: 3731737
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxic alcohol-induced, acute intrahepatic cholestasis with reversible increase of the CA 19-9 tumor marker in chronic alcoholic hepatitis].
    Griga T; May B
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():62-3. PubMed ID: 7483717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis.
    Duvoux C; Radier C; Roudot-Thoraval F; Maille F; Anglade MC; Van Nhieu JT; Rosa I; Hospitel S; Abd-Alsamad I; Sitruk V; Seror O; Ziol M; Blondon H; Dhumeaux D; Richardet JP
    Hepatology; 2004 Dec; 40(6):1370-8. PubMed ID: 15565651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.
    Mathurin P; Beuzin F; Louvet A; Carrié-Ganne N; Balian A; Trinchet JC; Dalsoglio D; Prevot S; Naveau S
    Aliment Pharmacol Ther; 2007 May; 25(9):1047-54. PubMed ID: 17439505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alcoholic foamy steatosis: study of 3 cases].
    Fléjou JF; Degott C; Kharsa G; Soulier A; Rueff B; Potet F
    Gastroenterol Clin Biol; 1987 Feb; 11(2):165-8. PubMed ID: 3569739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcoholic liver disease in man (1911-1979)--a probing review--Part II.
    Bhagwat AG; Islam M
    Indian J Pathol Microbiol; 1980 Jan; 23(1):73-87. PubMed ID: 7011958
    [No Abstract]   [Full Text] [Related]  

  • 19. Portal lymphocytic infiltrate in alcoholic liver disease.
    Colombat M; Charlotte F; Ratziu V; Poynard T
    Hum Pathol; 2002 Dec; 33(12):1170-4. PubMed ID: 12514784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organ changes in chronic alcoholism].
    Lao B
    Pol Tyg Lek; 1978 May; 33(18):743-5. PubMed ID: 351587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.